Compare AGIO & OPRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AGIO | OPRA |
|---|---|---|
| Founded | 2007 | 1996 |
| Country | United States | Norway |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.7B |
| IPO Year | 2013 | 2018 |
| Metric | AGIO | OPRA |
|---|---|---|
| Price | $33.62 | $18.26 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 1 |
| Target Price | ★ $38.88 | $21.50 |
| AVG Volume (30 Days) | ★ 777.0K | 370.8K |
| Earning Date | 04-29-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 4.61% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $43,011,000.00 | N/A |
| Revenue This Year | $76.75 | $21.29 |
| Revenue Next Year | $170.73 | $15.34 |
| P/E Ratio | ★ N/A | $13.62 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $22.24 | $11.71 |
| 52 Week High | $46.00 | $21.06 |
| Indicator | AGIO | OPRA |
|---|---|---|
| Relative Strength Index (RSI) | 48.19 | 38.62 |
| Support Level | $32.54 | $17.79 |
| Resistance Level | $36.04 | $19.58 |
| Average True Range (ATR) | 1.28 | 0.58 |
| MACD | 0.10 | -0.15 |
| Stochastic Oscillator | 42.77 | 20.19 |
Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236 and others.
Opera Ltd is a consumer internet software company providing a diversified portfolio of high-performance web browsers and adjacent digital services to engaged user base The company has transitioned from browser developer to multi-faceted platform offering a products and services that include PC and mobile browsers, its Opera Gaming portals and development tools, Opera News content platforms, Opera Ads platform, as well as a number of AI and web3 products and services, such as MiniPay and Opera AI, to a user base.